Hyperthermic Intraperitoneal Chemotherapy for Advanced Gastric Cancer With Peritoneal Metastatis
Status:
Unknown status
Trial end date:
2020-08-24
Target enrollment:
Participant gender:
Summary
The incidence rate of gastric cancer is high in Southeast Asia, so is the mortality rate.Due
to the lack of specific performance, about 5%-20% of patients have found peritoneal
metastases at the time of first diagnosis.At present, clinical studies on HIPEC in the
treatment of patients with advanced gastric cancer peritoneal metastasis are almost related
to abdominal perfusion after laparoscopic gastrectomy.Herein, we conduct a single-centre
randomized controlled trial to explore the safety and feasibility of laparoscopic exploration
combined with HIPEC in the treatment of advanced gastric cancer with peritoneal metastasis.
Phase:
Phase 2
Details
Lead Sponsor:
Guangdong Provincial Hospital of Traditional Chinese Medicine